-
1 week ago | 
ophthalmologytimes.com | Dilraj S. Grewal |Sydney M Crago |Kassi Filkins
Dilraj S. Grewal, MD, FASRS, an associate professor of ophthalmology at Duke Eye Center, spoke with Ophthalmology Times at the 2025 Retina World Congress meeting held in Fort Lauderdale, Florida. At this meeting, Grewal gave a presentation entitled, "New therapeutics for non-infectious uveitis in 2025," which provided an in-depth overview of the current state of research and treatment innovations. Note: This conversation has been lightly edited for clarity.
-
1 week ago | 
ophthalmologytimes.com | Priya S. Vakharia |Sydney M Crago |Kassi Filkins
Priya S. Vakharia, MD, a retina specialist at Retina Vitreous Associates of Florida in Tampa Bay, presented findings from the ARCHER trial investigating geographic atrophy (GA) treatment for dry age-related macular degeneration (AMD) during the 2025 Retina World Congress annual meeting. Note: The following conversation has been lightly edited for clarity. Ophthalmology Times: You presented on the ARCHER trial here at Retina World Congress. Can you give us a few highlights from this presentation?
-
1 week ago | 
ophthalmologytimes.com | Sydney M Crago |Sunir J. Garg |Kassi Filkins
Sunir Garg, MD, a professor of ophthalmology at Wills Eye Hospital and partner with Mid-Atlantic Retina, discussed with Ophthalmology Times one significant challenge in ophthalmological procedures: patient discomfort during intravitreal injections caused by povidone iodine. Note: The following conversation has been lightly edited for clarity. Ophthalmology Times: Can you share more about the the challenges behind current anti-sepsis options for intravitreal injections?
-
1 month ago | 
europe.ophthalmologytimes.com | Kassi Filkins
A pioneer of refractive laser eye surgery in the UK, Professor David Gartry, MD, FRCS, FRCOphth, FCOptom, reached the milestone in the 36th year of his career
-
1 month ago | 
optometrytimes.com | Martin Harp |Hattie Hayes |Kassi Filkins
April 21, 2025By The FDA did not agree with a supplemental Biologics License Application for the addition of extended dosing intervals of up to 24 weeks across currently-approved indications.
-
1 month ago | 
ophthalmologytimes.com | Martin Harp |Hattie Hayes |Kassi Filkins
The US Food and Drug Administration (FDA) has issued a complete response letter (CRL) to Regeneron Pharmaceuticals for its supplemental Biologics License Application (sBLA) for the addition of extended dosing intervals (up to every 24 weeks) for aflibercept Injection 8 mg (EYLEA HD) across all approved indications.1 According to the company, the CRL does not identify any safety or efficacy issues with aflibercept 8 mg, but the FDA did not agree with the company’s proposal to add additional...
-
Jan 28, 2025 | 
signalakron.org | Arielle Kass |Kassi Filkins
When Ebony Yeboah-Amankwah chaired the Akron Heart Walk last year, she was struck by a statistic she heard about the high number of people in Summit and Portage counties who didn’t have access to fresh food in grocery stores. Yeboah-Amankwah couldn’t verify the figures, but the idea stuck with her: There are a lot of people in the area who live in food deserts. She wanted to help make a difference for them, improving their access to fresh food.
-
Jan 22, 2025 | 
signalakron.org | Kassi Filkins |Kassi Jackson
As extreme cold weather continues in Northeast Ohio, know the signs of hypothermia and frostbite and how to stay safe. Anyone exposed to cold temperatures for lengths of time is susceptible to frostbite, which is skin damage caused by below-freezing temperatures and can lead to permanent, irreversible tissue damage called necrosis. Frostbite can leave its mark in as little as 30 minutes (sometimes less) when temperatures are -15 degrees or colder.
-
Aug 9, 2024 | 
signalakron.org | Kassi Filkins |Reegan Davis Saunders |Brittany Moseley |Andrew Keiper |Kassi Jackson
In the almost two years Melody Hale has lived in her house on Storer Avenue, she has never experienced flooding like what happened Thursday night. “It was like somebody had just taken a hose and stuck it under the door, and water was just coming in,” said Hale, who lives in the home with her daughter, CC Mathis, and her granddaughter. As heavy rain pummeled the west side of Akron, Hale’s basement filled with two feet of water.
-
Aug 5, 2024 | 
signalakron.org | Kassi Filkins |Kassi Jackson
The Akron Zoo plans to break ground in 2025 on a nearly 12,000-square-foot veterinary hospital. The facility will be located behind the Landon & Cynthia Knight Pride of Africa and is intended to help meet the needs of the zoo as it continues to grow — it will open in 2026. Ohio House Bill 2 earmarked $2 million toward the projected cost of nearly $12 million. The remainder of the funding will come from donors and the zoo’s budget.
